表观遗传抑制剂及其在癌症治疗中的作用。

3区 生物学 Q1 Biochemistry, Genetics and Molecular Biology International review of cell and molecular biology Pub Date : 2023-01-01 DOI:10.1016/bs.ircmb.2023.04.005
Nouha Abdelaziz, Lubna Therachiyil, Hana Q Sadida, Ateeque Mohamed Ali, Omar S Khan, Mayank Singh, Abdul Q Khan, Ammira S Al-Shabeeb Akil, Ajaz A Bhat, Shahab Uddin
{"title":"表观遗传抑制剂及其在癌症治疗中的作用。","authors":"Nouha Abdelaziz,&nbsp;Lubna Therachiyil,&nbsp;Hana Q Sadida,&nbsp;Ateeque Mohamed Ali,&nbsp;Omar S Khan,&nbsp;Mayank Singh,&nbsp;Abdul Q Khan,&nbsp;Ammira S Al-Shabeeb Akil,&nbsp;Ajaz A Bhat,&nbsp;Shahab Uddin","doi":"10.1016/bs.ircmb.2023.04.005","DOIUrl":null,"url":null,"abstract":"<p><p>Epigenetic modifications to DNA are crucial for normal cellular and biological functioning. DNA methylation, histone modifications, and chromatin remodeling are the most common epigenetic mechanisms. These changes are heritable but still reversible. The aberrant epigenetic alterations, such as DNA methylation, histone modification, and non-coding RNA (ncRNA)-mediated gene regulation, play an essential role in developing various human diseases, including cancer. Recent studies show that synthetic and dietary epigenetic inhibitors attenuate the abnormal epigenetic modifications in cancer cells and therefore have strong potential for cancer treatment. In this chapter, we have highlighted various types of epigenetic modifications, their mechanism, and as drug targets for epigenetic therapy.</p>","PeriodicalId":14422,"journal":{"name":"International review of cell and molecular biology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Epigenetic inhibitors and their role in cancer therapy.\",\"authors\":\"Nouha Abdelaziz,&nbsp;Lubna Therachiyil,&nbsp;Hana Q Sadida,&nbsp;Ateeque Mohamed Ali,&nbsp;Omar S Khan,&nbsp;Mayank Singh,&nbsp;Abdul Q Khan,&nbsp;Ammira S Al-Shabeeb Akil,&nbsp;Ajaz A Bhat,&nbsp;Shahab Uddin\",\"doi\":\"10.1016/bs.ircmb.2023.04.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Epigenetic modifications to DNA are crucial for normal cellular and biological functioning. DNA methylation, histone modifications, and chromatin remodeling are the most common epigenetic mechanisms. These changes are heritable but still reversible. The aberrant epigenetic alterations, such as DNA methylation, histone modification, and non-coding RNA (ncRNA)-mediated gene regulation, play an essential role in developing various human diseases, including cancer. Recent studies show that synthetic and dietary epigenetic inhibitors attenuate the abnormal epigenetic modifications in cancer cells and therefore have strong potential for cancer treatment. In this chapter, we have highlighted various types of epigenetic modifications, their mechanism, and as drug targets for epigenetic therapy.</p>\",\"PeriodicalId\":14422,\"journal\":{\"name\":\"International review of cell and molecular biology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International review of cell and molecular biology\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1016/bs.ircmb.2023.04.005\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International review of cell and molecular biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/bs.ircmb.2023.04.005","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

摘要

表观遗传修饰的DNA是至关重要的正常细胞和生物功能。DNA甲基化、组蛋白修饰和染色质重塑是最常见的表观遗传机制。这些变化是可遗传的,但仍然是可逆的。异常的表观遗传改变,如DNA甲基化、组蛋白修饰和非编码RNA (ncRNA)介导的基因调控,在包括癌症在内的各种人类疾病的发生中发挥着重要作用。最近的研究表明,合成和膳食表观遗传抑制剂可以减弱癌细胞中异常的表观遗传修饰,因此具有很强的癌症治疗潜力。在本章中,我们重点介绍了各种类型的表观遗传修饰,它们的机制,以及作为表观遗传治疗的药物靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Epigenetic inhibitors and their role in cancer therapy.

Epigenetic modifications to DNA are crucial for normal cellular and biological functioning. DNA methylation, histone modifications, and chromatin remodeling are the most common epigenetic mechanisms. These changes are heritable but still reversible. The aberrant epigenetic alterations, such as DNA methylation, histone modification, and non-coding RNA (ncRNA)-mediated gene regulation, play an essential role in developing various human diseases, including cancer. Recent studies show that synthetic and dietary epigenetic inhibitors attenuate the abnormal epigenetic modifications in cancer cells and therefore have strong potential for cancer treatment. In this chapter, we have highlighted various types of epigenetic modifications, their mechanism, and as drug targets for epigenetic therapy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International review of cell and molecular biology
International review of cell and molecular biology BIOCHEMISTRY & MOLECULAR BIOLOGY-CELL BIOLOGY
CiteScore
7.70
自引率
0.00%
发文量
67
审稿时长
>12 weeks
期刊介绍: International Review of Cell and Molecular Biology presents current advances and comprehensive reviews in cell biology-both plant and animal. Articles address structure and control of gene expression, nucleocytoplasmic interactions, control of cell development and differentiation, and cell transformation and growth. Authored by some of the foremost scientists in the field, each volume provides up-to-date information and directions for future research.
期刊最新文献
Role of chemokine receptors in transplant rejection and graft-versus-host disease. Chemokine receptors and their ligands in breast cancer: The key roles in progression and metastasis. Role of chemokine receptors in gastrointestinal mucosa. Chemotactic signaling pathways in prostate cancer: Implications in the tumor microenvironment and as potential therapeutic targets. Chemokine receptors in primary and secondary lymphoid tissues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1